Review for "Use of SGLT‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: an Asian perspective and expert recommendations"

Author(s):  
Naotake Hashimoto
Sign in / Sign up

Export Citation Format

Share Document